Cell-impedance-based label-free technology for the identification of new drugs

References

• Ekwall B. Screening of toxic compounds in mammalian cell cultures. Ann NY Acad Sci. 1983;407:64–77.
   PubMed Web of Science ®Google Scholar
• Bellamy WT. Prediction of response to drug therapy of cancer. A review of in vitro assays. Drugs. 1992;44:690–708.
   PubMed Web of Science ®Google Scholar
• Lyne TB, Bickham JW, Lamb T, et al. The application of bioassays in risk assessment of environmental pollution. Risk Anal. 1992;12:361–365.
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Roth J, Pastan I. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay to polypeptide hormones in plasma. Science. 1970;170:633–635.
   PubMed Web of Science ®Google Scholar
• Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639–650.
   PubMed Web of Science ®Google Scholar
• Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999;18:1723–1729.
   PubMed Web of Science ®Google Scholar
• Lundstrom K. Present and future drug discovery on G protein-coupled receptors. Fut Med Chem. 2013;5:523–528.
   PubMed Web of Science ®Google Scholar
• Eribol P, Uguz AK, Ulgen KO. Screening applications in drug discovery based on microfluidic technology. Biomicrofluidics. 2016;10:011502.
   Google Scholar
• Barata D, van Bitterswijk C, Habibovic P. High-throughput screening approaches and combinatorial development of biomaterials using microfluidics. Acta Biomater. 2016;34:1–20.
   PubMed Web of Science ®Google Scholar
• Wang M, Mao Z, Kang T-S, et al. Conjugating a groove-binding motif to an Ir(III) complex for the enhancement of G-quadruplex probe behavior. Chem Sci. 2016;7:2516.
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang L, Shen J, et al. An individual nanocube-based plasmonic biosensor for real-time monitoring the structural switch of the telomeric G-quadruplex. Small. 2016;12:2913–2920.
   PubMed Web of Science ®Google Scholar
• Ma DL, Wang M, Liu C, et al. Metal complexes for the detection of disease-related protein biomarkers. Coord Chem Rev. 2016;324:90–105.
   Web of Science ®Google Scholar
• Ma DL, Shan D, Yang H, et al. Luminescent G-quadruplex probes. Curr Phramaceut Design. 2012;18:2058–2075.
   PubMed Web of Science ®Google Scholar
• Leong V, Seidler MA, Steiner M, et al. Time-resolved scattering of a single photon by a single atom. Nat Commun. 2016;7:13716.
   PubMed Web of Science ®Google Scholar
• Heifetz A, James T, Morao I, et al. Guiding lead optimization with GPCR structure modeling and molecular dynamism. Curr Opin Pharmacol. 2016;30:14–21.
   PubMed Web of Science ®Google Scholar
• Leelananda SP, Lindert S. Computational methods in drug discovery. Beilstein J Org Chem. 2016;12:2694–2718.
   PubMed Web of Science ®Google Scholar
• Cherezov V, Rosenbaum DM, Hanson MA, et al. High-resolution structure of an engineered human beta-2 adrenergic G protein-coupled receptor. Science. 2007;318:1258–1265.
   PubMed Web of Science ®Google Scholar
• Warne T, Serrano-Vega MJ, Baker JG, et al. Structure of a beta-1 adrenergic G protein-coupled receptor. Nature. 2008;454:486–491.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang K, Li XD, et al. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure. Biomed Pharmacother. 2016;84:147–157.
   PubMed Web of Science ®Google Scholar
• Ma D-L, Chan D, Lee P, et al. Molecular modeling of drug DNA interactions: virtual screening to structure-based design. Biochimie. 2011;93:1252–1265.
   PubMed Web of Science ®Google Scholar
• Ma D-L, Chan D, Leung C-H. Drug repositioning by structure-based virtual screening. Chem Soc Rev. 2013;42:2130–2141.
   PubMed Web of Science ®Google Scholar
• Veljkovic V, Veljkovic N, Este J, et al. Application of the EIIP/ISM bioinformatics concept in development of new drugs. Curr Med Chem. 2007;14:441–453.
   PubMed Web of Science ®Google Scholar
• An WF, Tolliday N. Cell-based assays for high-throughput screening. Mol Biotechnol. 2010;45:180–186.
   PubMed Web of Science ®Google Scholar
• Wunder F, Kalthof B, Müller T, et al. Functional cell-based assays in microliter volumes for ultra-high throughput screening. Comb Chem High Throughput Screen. 2008;11:495–504.
   PubMed Web of Science ®Google Scholar
• Galluzi L, Karp M. Whole cell strategies based on lux genes for high throughput applications toward new antimicrobials. Comb Chem High Throughput Screen. 2006;9:501–514.
   PubMed Web of Science ®Google Scholar
• Minor LK. Label-free cell-based functional assays. Comb Chem High Throughput Screen. 2008;11:573–580.
   PubMed Web of Science ®Google Scholar
• Ke N, Nguyen K, Irelan J, et al. Multidimensional GPCR profiling and screening using impedance-based label-free and real-time assay. Methods Mol Biol. 2015;1272:215–226. DOI:10.1007/978-1-4939-2336-6_15
   PubMedGoogle Scholar
• Scott CW, Peters MF. Label-free whole-cell assays: expanding the scope of GPCR screening. Drug Discov Today. 2010;15:704–716.
   PubMed Web of Science ®Google Scholar
• Heilker R, Wolff M, Tautermann CS, et al. G protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today. 2009;14:231–240.
   PubMed Web of Science ®Google Scholar
• Landry JP, Fei Y, Zhu X, et al. Discovering small molecule ligands of vascular epithelial growth factor that block VEGFR-KDR binding using label-free microarray-based assays. Assay Drug Dev Technol. 2013;1:326–332.
   Web of Science ®Google Scholar
• Paz K, Zhu Z. Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective. Front Biosci. 2005;10:1415–1439.
   PubMed Web of Science ®Google Scholar
• Ona T, Shibata J. Advanced dynamic monitoring of cellular status using label-free and non-invasive cell-based sensing technology for the prediction of anticancer drug efficacy. Anal Bioanal Chem. 2010;398:2505–2533.
   PubMed Web of Science ®Google Scholar
• Mestres-Ventura P. Chemosensitivity testing of human tumors using Si-sensor chips. Recent Results Cancer Res. 2003;161:26–38.
   PubMedGoogle Scholar
• Killerich-Pedersen K, Rozlosnik N. Cell-based biosensors: electrical sensing in microfluidic devices. Diagnostics. 2012;2:83–96.
   Google Scholar
• Ditto NT, Brooks BD. The emerging role of biosensor-based epitope binning and mapping in antibody-based drug discovery. Expert Opin Drug Discov. 2016;11:925–937.
   PubMed Web of Science ®Google Scholar
• Abdiche YN, Miles A, Eckman J. High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity. PLoS One. 2014;9:e92451.
   PubMed Web of Science ®Google Scholar
• Concepcion J, Witte K, Wartchow C, et al. Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High Throughput Screen. 2009;12:791–800.
   PubMed Web of Science ®Google Scholar
• Endo T, Yamamura S, Kerman K, et al. Label-free cell-based assay using localized surface plasmon resonance biosensor. Anal Chim Acta. 2008;614:182–189.
   PubMed Web of Science ®Google Scholar
• Yanase Y, Hiragun T, Ishii K, et al. Surface plasmon resonance for cell-based clinical diagnosis. Sensors. 2014;14:4948–4959.
   PubMed Web of Science ®Google Scholar
• Berns EJ, Cabezas MD, Mrksich M. Cellular assays with a molecular endpoint measured by SAMDI mass spectrometry. Small. 2016;12:3811–3818.
   PubMed Web of Science ®Google Scholar
• Maki T. Quantitative approach for small molecules using laser desorption/ionization mass spectrometry. Biol Pharm Bull. 2012;35:1413–1416.
   PubMed Web of Science ®Google Scholar
• Grundmann M, Kostenis E. Label-free biosensor assays in GPCR screening. Methods Mol Biol. 2015;1272:199–213.
   PubMedGoogle Scholar
• Zauber H, Szymanski W, Schulze WX. Unraveling sterol-dependent membrane phenotypes by analysis of protein abundance-ration distributions in different membrane fractions under biochemical and steroid depletion. Mol Cell Proteomics. 2013;12:3732–3743.
   PubMed Web of Science ®Google Scholar
• Tran TB, Cho S, Min J. Hydrogel-based diffusion chip with Electric Cell-substrate Impedance Sensing (ECIS) integration for cell viability assay and drug toxicity screening. Biosens Biolectron. 2013;50:453–459.
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Bennet D, Kim S. Drug and bioactive molecule screening based on bioelectrical impedance cell culture platform. Int J Nanomedicine. 2014;9:5789–5809.
   PubMed Web of Science ®Google Scholar
• Seeland S, Török M, Kettiger H, et al. A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells. Toxicol In Vitro. 2013;27:1109–1120.
   PubMed Web of Science ®Google Scholar
• Beckers S, Noor F, Müller-Vieira U, et al. High-throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements. Toxicol In Vitro. 2010;24:686–694.
   PubMed Web of Science ®Google Scholar
• Ziolkowska K, Stelmachowska A, Kwapiszewski R, et al. Long-term three-dimensional cell culture and anticancer drug activity evaluation in a microfluidic chip. Biosens Biolectron. 2013;40:68–74.
   PubMed Web of Science ®Google Scholar
• Wu MH, Huang SB, Lee GB. Microfluidic cell culturesystems for drug research. Lab Chip. 2010;20:939–956.
   Web of Science ®Google Scholar
• Krinke D, Jahnke HG, Pänke O, et al. A microelectrode-based sensor for label-free in vitro detection of ischemic effects on cardiomyocytes. Biosens Bioelectron. 2009;24:2798–2803.
   PubMed Web of Science ®Google Scholar
• Jahnke HG, Krinke D, Seidel D, et al. A novel 384-multiwell microelectrode array for the impedimetric monitoring of Tau protein induced neurodegenerative processes. Biosens Bioelectron. 2017;88:78–84.
   PubMed Web of Science ®Google Scholar
• Härmä H, Rozwandowicz-Jansen A, Martikkala E, et al. A new simple cell-based homogenous time-resolved fluorescence QRET technique for receptor-ligand interaction screening. J Biomol Screen. 2009;14:936–943.
   PubMedGoogle Scholar
• Cooper MA. Advances in membrane receptor screening and analysis. J Mol Recognit. 2004;17:286–315.
   PubMed Web of Science ®Google Scholar
• Halai R, Cooper MA. Using label-free screening technology to improve efficiency in drug discovery. Expert Opin Drug Discov. 2012;7:123–131.
   PubMed Web of Science ®Google Scholar
• Solly K, Wang X, Xu X, et al. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol. 2004;2:363–372.
   PubMed Web of Science ®Google Scholar
• Yu N, Atienza JM, Bernard J, et al. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal Chem. 2006;78:35–43.
   PubMed Web of Science ®Google Scholar
• Fang Y, Frutos AG, Verklereen A. Label-free cell-based assays for GPCR screening. Comb Chem High Throughput Screen. 2008;11:357–369.
   PubMed Web of Science ®Google Scholar
• Lee PH. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification. J Recept Signal Transd Res. 2009;29:146–153.
   PubMed Web of Science ®Google Scholar
• Cunningham BT, Laing L. Microplate-based, cell-free detection of biomolecular interactions: applications in proteomics. Expert Rev Proteomics. 2006;3:271–281.
   PubMed Web of Science ®Google Scholar
• Cunningham BT, Laing LG. Advantages and application of label-free detection assays in drug screening. Expert Opin Drug Discov. 2008;3:891–901.
   PubMed Web of Science ®Google Scholar
• Qureshi A, Pandy A, Chouhan RS, et al. Whole-cell based label-free capacitive biosensor for rapid nanosize-dependent toxicity detection. Biosens Bioelectron. 2015;67:100–106.
   PubMed Web of Science ®Google Scholar
• Schwarzenberger T, Wolf P, Brischwein M, et al. Impedance sensor technology for cell-based assays in the framework of a high-content screening system. Physiol Meas. 2011;32:977–993.
   PubMed Web of Science ®Google Scholar
• Wolf P, Brischwein M, Kleinhans R, et al. Automated platform for sensor-based monitoring and controlled assays of living cells and tissues. Biosens Bioelectron. 2013;50:111–117.
   PubMed Web of Science ®Google Scholar
• Atienza JM, Yu N, Wang X, et al. Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array. J Biomol Screen. 2006;11:634–643.
   PubMed Web of Science ®Google Scholar
• Proll G, Steinle L, Pröll F, et al. Potential of label-free detection in high-content screening applications. J Chromatogr A. 2007;1161:2–8.
   PubMed Web of Science ®Google Scholar
• Atienzar FA, Gerets H, Tilmant K, et al. Evaluation of impedance-based cell-free technology as a tool for pharmacology and toxicology investigations. Biosensors. 2013;3:132–156.
   Google Scholar
• xCELLigence System RCTA HT Instrument, High-throughput GPCR Screening. xCELLigence System Application Note No 16. ACEA Biosciences Inc; 2013. Available from: www.aceabio.com
   Google Scholar
• Scrace S, O’Neill E, Hammond EM, et al. Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions. Methods Mol Biol. 2013;1046:295–306.
   PubMedGoogle Scholar
• Meindl C, Absenger M, Roblegg E, et al. Suitability of cell-based label-free detection for cytotoxicity screening of carbon nanotubes. Biomed Res Int. 2013;2013:564804.
   PubMed Web of Science ®Google Scholar
• Kho D, MacDonald C, Johnson R, et al. Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time. Biosensors. 2015;5:199–222.
   PubMedGoogle Scholar
• McGuinness RP, Proctor JM, Gallant DL, et al. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology. Comb Chem High Throughput Screen. 2009;12:812–823.
   PubMed Web of Science ®Google Scholar
• Peters MF, Vaillancourt F, Heroux M, et al. Comparing label-free biosensors for pharmacological screening with cell-based functional assays. Assay Drug Dev Technol. 2010;8:219–227.
   PubMed Web of Science ®Google Scholar
• Owen RM, Wang C, You JA, et al. Real-time quantitation of viral replication and inhibitor potency using a label-free optical biosensor. J Recept Signal Transd Res. 2009;29:195–201.
   PubMed Web of Science ®Google Scholar
• Mestres P, Morguet A. The Bionas technology for anticancer drug screening. Exp Opin Drug Discov. 2009;4:785–797.
   PubMed Web of Science ®Google Scholar
• Arias LR, Perry CA, Yang L. Real-time electrical impedance detection of cellular activities of oral cancer cells. Biosens Bioelectron. 2010;25:2225–2231.
   PubMed Web of Science ®Google Scholar
• Langer G. Implementation and use of state-of-the-art, cell-based in vitro assays. Handb Exp Pharmacol. 2016;232:171–190.
   PubMedGoogle Scholar
• Zehender H, Mayr LM. Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein-protein interactions. Curr Opin Chem Biol. 2007;11:511–517.
   PubMed Web of Science ®Google Scholar
• Holt TG, Choj BK, Geoghagen NS, et al. Label-free high-throughput screening via mass spectrometry: a single cystathionine quantitative method for multiple applications. Assay Drug Dev Technol. 2009;7:495–506.
   PubMed Web of Science ®Google Scholar
• Pavelev RA, Mansour NR, Hallyburton I, et al. Whole organism high-content screening by label-free, image-based Bayesian classification for parasite diseases. PLoS Neg Trop Dis. 2012;6:e1762.
   Google Scholar
• Atienza JM, Yu N, Kirstein SL, et al. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol. 2006;4:597–607.
   PubMed Web of Science ®Google Scholar
• Thomsen W, Frazer J, Unett D. Functional assays for screening GPCR targets. Curr Opin Biotechnol. 2005;16:655–665.
   PubMed Web of Science ®Google Scholar
• Grundmann M, Tikhonova IG, Hudson BD, et al. A molecular mechanism for sequential activation of a G protein-coupled receptor. Cell Chem Biol. 2016;23:392–403.
   PubMed Web of Science ®Google Scholar
• Dohlman HG. Thematic minireview series: new directions in G protein-coupled receptor pharmacology. J Biol Chem. 2015;290:19469–19470.
   PubMed Web of Science ®Google Scholar
• Vela L, Lowe PN, Gerstenmaier J, et al. Validation of an optical microplate label-free platform in the screening of chemical libraries for direct binding to a nuclear receptor. Assay Drug Dev Technol. 2011;9:532–548.
   PubMed Web of Science ®Google Scholar
• Buehler SM, Stubbe M, Gimsa U, et al. A decrease of intracellular ATP is compensated by increased respiration and acidification at sub-lethal parathion concentrations in murine embryonic neuronal cells: measurements in metabolic cell-culture chips. Toxicol Lett. 2011;207:182–190.
   PubMed Web of Science ®Google Scholar
• Heileman K, Daoud J, Tabrizian M. Dielectric spectroscopy as a viable biosensing tool for cell and tissue characterization and analysis. Biosens Bioelectron. 2013;49:348–359.
   PubMed Web of Science ®Google Scholar
• Kustermann S, Boess F, Buness A, et al. A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects. Toxicol In Vitro. 2013;27:1589–1595.
   PubMed Web of Science ®Google Scholar
• Irelan J, Morgan JH. Functional profiling of endogenous GPCRs using the xCelligence system. Roche Focus Appl. 2010. Note 7, Mat No 05864542001.
   Google Scholar
• Suter L, Babiss LE, Wheeldon EB. Toxicogenomics in predictive toxicology in drug development. Chem Biol. 2004;11:161–171.
   PubMed Web of Science ®Google Scholar